NCT01931644
- Conditions
- ADD/ADHD, Abnormalities, Multiple, Acquired Immunodeficiency Syndrome, +282 more
- Locations
-
- Sanguine Biosciences Los Angeles, California, United States
Clinical trial condition
Multiple Myeloma
Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.
1,662 public trials
323 recruiting studies
Multiple Myeloma trial results
NCT02157636
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
Completed
Stage I Multiple Myeloma Treatment
NCT00733538
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Service de Medecine interne, Hôpital l'ARCHET, CHU de Nice Nice, France
NCT06359067
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Assistance Publique - Hôpitaux de Paris (AP-HP) Paris, IDF, France
NCT03848845
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- GSK Investigational Site Atlanta, Georgia, United States
- GSK Investigational Site Indianapolis, Indiana, United States
- GSK Investigational Site Charlotte, North Carolina, United States
- GSK Investigational Site Madison, Wisconsin, United States
Completed
Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide
NCT06069024
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +16 more
- Locations
-
- the First Affiliated Hospital of Shandong First Medical University Jinan, Shandong, China
NCT05306587
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Odense University Hospital Odense, Denmark
Completed
Bone Healing During Ninlaro Exposure
NCT04028115
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Odense University Hospital Odense, Denmark
Completed
Isatuximab Single Agent Study in Japanese Relapsed AND Refractory Multiple Myeloma Patients
NCT02812706
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Investigational Site Number :392001 Nagoya, Aichi-ken, Japan
- Investigational Site Number :392005 Shibukawa-shi, Gunma, Japan
- Investigational Site Number :392010 Hiroshima, Japan
- Investigational Site Number :392015 Kanazawa, Ishikawa-ken, Japan
NCT02891811
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Medizinische Universitaet Graz, Univ.-Klinik f. Innere Medizin, Onkologie Graz, Austria
- Med. Universität Innsbruck, Univ.-Klinik f. Innere Medizin V, Hämatologie u. Onkologie Innsbruck, Austria
- Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik Kufstein, Austria
- LKH Hochsteiermark - Standort Leoben Abteilung für Innere Medizin und Hämatologie und internistische Onkologie Leoben, Austria